Home » Stocks » LH

LabCorp (LH)

Stock Price: $198.85 USD 2.21 (1.12%)
Updated December 4, 4:00 PM EST - Market closed

LH Stock Price Chart

Key Info

Market Cap 19.37B
Revenue (ttm) 12.44B
Net Income (ttm) 844.90M
Shares Out 97.40M
EPS (ttm) 8.62
PE Ratio 23.06
Forward PE 11.85
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 4
Last Price $198.85
Previous Close $196.64
Change ($) 2.21
Change (%) 1.12%
Day's Open 197.00
Day's Range 195.87 - 199.34
Day's Volume 1,078,796
52-Week Range 104.32 - 214.42

LH Stock News

Zacks Investment Research - 1 day ago

LabCorp (LH) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research - 1 day ago

To beat the pandemic blues and maximize capital gains, investors can now scoop up these fundamentally-strong MedTech growth stocks.

Other stocks mentioned: IDXX, TMO
Zacks Investment Research - 2 days ago

Top Ranked Growth Stocks to Buy for December 3rd

Other stocks mentioned: HIBB, MTSI, ODP
Zacks Investment Research - 3 days ago

LH vs. CNMD: Which Stock Is the Better Value Option?

Zacks Investment Research - 3 days ago

Here are a few coronavirus-testing MedTech stocks that investors can scoop up to reap profits amid the pandemic-battered stock market situation.

Other stocks mentioned: HOLX, PKI, TMO
Zacks Investment Research - 1 week ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 1 week ago

A company that is capable of generating earnings well above its interest expense can withstand financial hardships.

Zacks Investment Research - 1 week ago

Top Ranked Growth Stocks to Buy for November 27th

Other stocks mentioned: HIBB, OMI
Zacks Investment Research - 1 week ago

After a detailed study of Driehaus' strategy, AAII concluded that it mainly focuses on strong earnings growth rates and impressive prospects to pick potential outperformers.

Other stocks mentioned: BLD, FICO, HOLX, QDEL
Zacks Investment Research - 1 week ago

LabCorp's (LH) Patient Direct offering will be used here to help in bringing suitable clinical trials to eligible patients directly.

Zacks Investment Research - 1 week ago

Top Ranked Growth Stocks to Buy for November 25th

Other stocks mentioned: HOLX, MTSI, ODP
Business Wire - 1 week ago

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that membe...

Zacks Investment Research - 1 week ago

P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects. Some such stocks are LH, ODP, HMC, SPB and BCC.

Other stocks mentioned: BCC, HMC, ODP, SPB
Zacks Investment Research - 2 weeks ago

Top Ranked Growth Stocks to Buy for November 20th

Other stocks mentioned: GM, JELD, OMI
Zacks Investment Research - 2 weeks ago

At this stage, it makes good sense to buy those stocks on the dip that could prove to be valuable once the rally resumes. These are Office Depot (ODP), WESCO (WCC), General Motors (GM), Labora...

Other stocks mentioned: GM, KNX, ODP, WCC
Investors Business Daily - 2 weeks ago

Laboratory Corporation Of America saw its IBD SmartSelect Composite Rating jump to 97 Thursday, up from 94 the day before. The post Lab Corp. Stock Passes Composite Rating Test With Flying Col...

Zacks Investment Research - 2 weeks ago

LabCorp (LH) could produce exceptional returns because of its solid growth attributes.

Zacks Investment Research - 2 weeks ago

Is (LH) Outperforming Other Medical Stocks This Year?

Zacks Investment Research - 2 weeks ago

Top Ranked Growth Stocks to Buy for November 17th

Other stocks mentioned: APAM, GM, HOLX
Zacks Investment Research - 3 weeks ago

Top Ranked Growth Stocks to Buy for November 13th

Other stocks mentioned: CWH, GM, IIVI
Seeking Alpha - 3 weeks ago

LabCorp is a mission-critical company that has been on the forefront of testing for COVID-19. I'm encouraged by the strong revenue backlog of its Covance drug development business, and by the ...

Zacks Investment Research - 3 weeks ago

PEG-based investing can turn out to be even more rewarding if some other relevant parameters are also taken into consideration.

Other stocks mentioned: KR, SNA, TAP, WHR
Investors Business Daily - 3 weeks ago

Laboratory Corporation Of America shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. The post Laboratory Corp. Of America Profit Nearly Triples, Flashes...

Zacks Investment Research - 3 weeks ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

OTC PR Wire - 3 weeks ago

The Virus Testing Stocks Pullback Opportunity (NASDAQ: CODX) (NASDAQ: FLGT) (OTC: ALST) (NYSE: LH)

Other stocks mentioned: CODX, FLGT, ALST
Zacks Investment Research - 3 weeks ago

Investors who have the propensity to take a higher risk can think of investing in momentum stocks to boost their gains.

Other stocks mentioned: AJG, FBK, HOLX, IRBT
Zacks Investment Research - 3 weeks ago

When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

Other stocks mentioned: ATCO, BCC, CSIQ, PAM, TEVA
Zacks Investment Research - 3 weeks ago

A company that is capable of generating earnings well above its interest expense can withstand financial hardships.

Other stocks mentioned: AGCO, DG, MTH, RUSHA
CNBC Television - 4 weeks ago

Cramer on four coronavirus testing stocks worth owning

"I bet the testing stocks have a lot more room to run," the "Mad Money" host said.

Other stocks mentioned: ABT, DGX, FLDM, HOLX, PKI, QDEL, TMO
Zacks Investment Research - 1 month ago

LabCorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Investment Research - 1 month ago

Investing opportunistically in growth stocks is the way to go in volatile markets.

Other stocks mentioned: GGB, SNBR, TPX
GuruFocus - 1 month ago

The Vanguard Health Care Fund (Trades, Portfolio) released its third-quarter portfolio earlier this week.

Other stocks mentioned: QDEL, ZLAB
CNBC - 1 month ago

"All of these names would work under both candidates," the "Mad Money" host said ahead of the presidential election.

Other stocks mentioned: ABT, AMZN, CLX, CMG, DPZ, EL, TGT, WMT
Insider Monkey - 1 month ago

In this article we will take a look at whether hedge funds think Laboratory Corp. of America Holdings (NYSE:LH) is a good investment right now. We check hedge fund and billionaire investor sen...

Business Wire - 1 month ago

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the 29th Annual Credit Suisse...

Zacks Investment Research - 1 month ago

Does LabCorp (LH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 1 month ago

LH vs. CNMD: Which Stock Is the Better Value Option?

Zacks Investment Research - 1 month ago

3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

Other stocks mentioned: ABC, ALGN, BDX, CAH, COO, HSIC, MCK, PDCO, WST, XRAY
Investors Business Daily - 1 month ago

On Wednesday, Laboratory Corporation Of America got an upgrade for its IBD SmartSelect Composite Rating from 92 to 98. The post LabCorp Earns Membership In 95-Plus Composite Rating Club appear...

Seeking Alpha - 1 month ago

Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 1 month ago

LabCorp (LH) Diagnostics business in Q3 grows significantly on organic volume improvements as a result of growing demand for COVID-19 testing.

Zacks Investment Research - 1 month ago

LabCorp (LH) delivered earnings and revenue surprises of 58.98% and 4.70%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 1 month ago

Shares of Laboratory Corp (NYSE:LH) moved higher by 0.5% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 190.00% over the past year to...

Business Wire - 1 month ago

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (or the Company) (NYSE: LH) today announced results for the third quarter ended September 30, 2020. “LabCorp remains committed to fighting the pandem...

Zacks Investment Research - 1 month ago

Under the extended alliance, LabCorp (LH) expects to expand its COVID-19 test capacity in the Seattle area.

Zacks Investment Research - 1 month ago

LabCorp (LH) closed the most recent trading day at $203.16, moving -1% from the previous trading session.

Zacks Investment Research - 1 month ago

LabCorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 month ago

In Q3, LabCorp (LH) significantly expands accessibility of PCR testing to reach underserved communities.

Business Wire - 1 month ago

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced new capabi...

Business Wire - 1 month ago

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Swedish, the largest n...

About LH

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The compan... [Read more...]

Industry
Diagnostics & Research
Founded
1971
CEO
David King
Employees
70,000
Stock Exchange
NYSE
Ticker Symbol
LH
Full Company Profile

Financial Performance

In 2019, LabCorp's revenue was $11.55 billion, an increase of 1.95% compared to the previous year's $11.33 billion. Earnings were $823.80 million, a decrease of -6.78%.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for LabCorp is 245.27, which is an increase of 23.34% from the latest price.

Price Target
$245.27
(23.34% upside)